63
63 DAFTAR PUSTAKA
1. Panggabean MM. Gagal jantung. In: Sudoyo AW, Setyohadi B, Alwi I, Simadibrata M, Setiati S, editor. Buku ajar ilmu penyakit dalam,4th ed, Jakarta: Pusat Penerbit Departemen Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Indonesia; 2006:p.1513-16.
2. Braunwald E. Heart failure and cor pulmonale, in : Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL, ed. Harrison’s principles of internal medicine, ed 16. McGraw-Hill, 2005. p1367-77.
3. Yancy et al, ACCF / American Heart Association Heart Failure Guideline: excecutive summary, 2013
4. RISKESDA 2007.
5. Merdawati, Haris Hasan. E-Journal FK USU Vol 1 no 1 , 2013 6. GB Antoni , Santalo M, Zapico-Mun BE, et al. N-terminal probrain
natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnea and ventricular dysfunction. The European Journal of Heart Failure 6 (2004) 301– 308. Elsevier
7. Hersunarti N, Rohman MS. Pemeriksaan BNP atau NT- proBNP pada Pasien Gagal Jantung. Kardiologi Indonesia J Kardiol Ind 2007; 28:229-232 ISSN 0126/3773. P: 229-32
8. Ozturk TC, Unluer E, Denizbasi A. Can NT-proBNP be used as a criterion for heart failure hospitalization in emergency room? J. Res Med Sci. 2011 December; 16(12): 1564–1571.
9. Ceyhan C, Unal S, Yenisey C, Tekten T, Ceyhan FB (2008). The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction-Correlation with echocardiographic indexes in hypertensive patients. Int. J. Cardiovasc. Imaging., 24: 253-259
64
64 shortness of breath. International Journal of Medicine and Medical Sciences Vol. 3(3), pp. 77-82, March 2011.
11. Salim AK, Siswanto BB, Basha A. Normal value of NT-ProBNP in Normal Indonesia Population. Buku Abstrak Pertemuan Ilmiah Tahunan IV PDS PATKLIN ; 25 – 27 November 2005; Malang, Indonesia
12. Anwaruddin S, LIoyd Jones DM, Baggish A, Chen A, Krauser D, Tung R et al. Renal Function, Congestive heart failure, and amino-terminal Pro-brain natriuretic measurement; result from the ProBNP Investigation of Dyspnea in the Emergency Department ( PRIDE ) Study. J Am Coll Cardiol 2006;47;917
13. Swanton RH, Banerjee S. Cardiac failure. In: Swanton’s Cardiology. 6th edition. Blackwell. 2008. P:255
14. Disalvo T. The Clinical Syndrome of Heart Failure. In: Heart Failure Acomprehensive Guide to Diagnosis and Treatment. Ed: G William Dec. Marcell Dekker. USA. P: 18,189.
15. Fuster V, Rourke RA, Walsh RA, Poole-Wilson P, King III SB, Robert R, et al. Hurst’s The Heart, ed 12. The McGraw-Hill Companies, 2008. Chapter 24, 25, 26.
16. Dumitru I. Heart Failure. Medscape, 2013.
17. Scoote M, Purcell IA, Poole-Wilson PA. Pathophysiology of Heart Failure. In; Essential Cardiology Principle and Practice. 2nd Edition. Ed: CLIVE ROSENDORFF. Humana Press. USA. P: 354-367
18. Herman et al. Basics of natriuretic peptides: practical aspects of assays, potential analytical confounders, and clinical interpretation. In : Markers in Cardiology. ed: Allan B Wu. Humana Press. USA 2003. P : 99-103
19. Maisel AM. Rapid Measurement OF B-Type Natriuretic Peptide in the Emergency Diagnosis of Hearth Failure. The New England Journal of Medicine. July 2008.
65
65 disease. In:Biomarkers in Heart Disease. 1st edition.Ed: James A de Lemos. American Heart Association. 2008. P:55-59
21. Maisel AM. Natriuretic peptide in clinical practice. In: marker in Cardiology. Ed: Jesse E Adam. Blackwell Publishing.USA.P:134-142.
22. Roundtable discussion. Testing for B-type natriuretic peptide in the diagnosis and assessment of heart failure: What are the nuances? Cleveland Clinic Juornal of Medicine. 2004
23. Doust J, Lehman R, Glasziou P. The Role of BNP Testing in Heart Failure. Am Fam Physician 2006;74:1893-8
24. Jackson G et al. ABC of heart failure Pathophysiology. British Medical Journal. BMJ Volume 320 15 January 2000
25. Dahlen JR. B-Type Natriuretic Peptide Biochemistry and Measurement. In: Markers in Cardiology. ed: Allan B Wu. Humana Press. USA 2003. P : 369-71
26. McCullough PA, Duc P, Omland T, et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 2003; 41:571–579
27. Weintraub NL et al. Acute Heart Failure Syndromes: Emergency Department Presentation, Treatment, and Disposition: Current Approaches and Future Aims : A Scientific Statement From the American Heart Association. Circulation Journal the American Heart Association. AHA. October 2010
28. Rademaker MT, Richard AM. Cardiac Natriuretic Peptide for cardiac health. Clin Sci ( Lond ).2005;108 (1):23-36
29. Pfister R et al. Use of NT-proBNP in routine testing and comparison to BNP. The European Journal of Heart Failure. Elsevier.2004
30. Boyars MC et al. Acute dyspea : a sign of underlying disease : review of clinical sign.Hospital physician july 2004.pp 23-27.
66
66
32. Roche. Cobas
33. Mulrow C, Lucey C, Farnett L. Diskriminating cause of dyspnea through the Clinical examination. J Gen Intern Med 1993;8:383-92.
34. Schmitt B, Kushrer M, Wiener S. The diagnostic usefulness of history of the patient with dyspnea. J Gen Intern Med 1986;386-93
35. Morrison KL, BS, et all, Journal of American College of Cardiology 2002, Elsevier Saence Inc. vol.39,no 2,2002.
36. Murray H, Cload B, Collier CP,et all, Potential impact of N-terminal pro-BNP testing on the emergency department evaluation of acute dyspnea. Can J Emerg Med 2006;8(4):251-8.
